BioticsAI CEO on FDA Approval and Building in Regulated Healthcare
Robhy Bustami, co-founder and CEO of BioticsAI, discussed the challenges of building a healthcare AI startup on the Build Mode podcast. His company developed an AI copilot for ultrasound to detect fetal abnormalities, an area with high misdiagnosis rates. The team built a working prototype for under $100,000, winning TechCrunch Startup Battlefield in 2023. In January, they secured FDA approval, enabling hospital deployment. Bustami emphasized early regulatory engagement and a culture of alignment to sustain team motivation through long timelines. BioticsAI now plans to expand beyond obstetrics into broader reproductive health.
Key facts
- BioticsAI developed an AI copilot for ultrasound to detect fetal abnormalities.
- The company won TechCrunch Startup Battlefield in 2023.
- BioticsAI gained FDA approval in January.
- The prototype was built for under $100,000.
- The team integrated clinical validation and regulatory strategy from day one.
- Early pre-submission meetings with regulators helped align study design.
- BioticsAI is now rolling out technology in hospitals.
- Plans include expanding into broader reproductive health areas.
Entities
Institutions
- BioticsAI
- TechCrunch
- FDA